Centre of Excellence in Women and Child Health, Pakistan

Medicine and Dentistry

1. Antibiotics 8%
2. Antiinfective Agent 5%
3. Arm 5%
4. Autosomal Recessive Disorder 9%
5. Autosomal Recessive Inheritance 52%
6. Awareness 14%
7. Biopsy Technique 12%
8. Birth Spacing 29%
9. Brain Disease 29%
10. Cancer Surgery 8%
11. Case Presentation 9%
12. Cell Surface Receptor 14%
13. Cleft Palate 29%
14. Clinical Finding 9%
15. Clinical Pathway 14%
16. Complement Component C1q 29%
17. Congenital Blindness 14%
18. Congenital Hypothyroidism 29%
19. Contraceptive Behavior 43%
20. Cross Sectional Study 65%
21. Curettage 29%
22. Cytoskeleton 7%
23. Developmental Delay 39%
24. Diagnostic Accuracy 9%
25. Disease 34%
26. Diseases 100%
27. Dried Blood Spot 7%
28. Dry Skin 14%
29. Epileptic Seizure 29%
30. Exome Sequencing 12%
31. External Ventricular Drain 5%
32. Facies 14%
33. Family Planning 58%
34. Fisher Exact Test 5%
35. Fresh Frozen Plasma 12%
36. Ganglioglioma 7%
37. Gene Linkage 14%
38. Genetic Condition 14%
39. Genetic Screening 9%
40. Glomerulonephritis 14%
41. Gut 5%
42. Health Care Cost 13%
43. Human Immunodeficiency Virus 29%
44. Human Poliovirus 1 8%
45. Human Subject 5%
46. Humoral Immunity 5%
47. Hypotonia 14%
48. Immune Deficiency 8%
49. Immune Response 5%
50. Immunoregulation 14%
51. Infantile Spasm 9%
52. Informed Consent 9%
53. Intracranial Tumor 29%
54. Intraepithelial Neoplasia 29%
55. Lactoferrin 29%
56. Maturation 10%
57. Mucosal Immunity 11%
58. Muscular Dystrophy 36%
59. Neonatal Infant 18%
60. Neonates 13%
61. Neoplasm 10%
62. Neuro-Oncology 29%
63. Newborn Screening 32%
64. Next Generation Sequencing 29%
65. Oral Poliomyelitis Vaccine 23%
66. Patient Referral 29%
67. Pediatric Endocrinologist 7%
68. Pediatrics 29%
69. Phosphotransferase 29%
70. Plasma Transfusion 8%
71. Poliomyelitis Vaccine 33%
72. Poliomyelitis Virus 41%
73. Predictor 29%
74. Preference 14%
75. Prenatal Care 14%
76. Prepregnancy Care 14%
77. Prevalence 20%
78. Primary Outcome 10%
79. Proliferative Retinopathy 29%
80. Proportional Hazards Model 14%
81. Prospective Cohort Study 29%
82. Quality of Life 29%
83. Randomized Controlled Trial 29%
84. Registration Number 5%
85. Reproductive Age 29%
86. Reproductive History 14%
87. Reproductive Public Health 18%
88. Respiratory Distress 19%
89. School-Aged Child 29%
90. Seroconversion 29%
91. Seroprevalence 29%
92. Skin Manifestation 43%
93. Spinal Muscular Atrophy 48%
94. Student T Test 5%
95. Synapse 7%
96. Tertiary Care 10%
97. Thyrotropin 21%
98. Typhoid Fever 29%
99. Typhoid Vaccine 29%
100. Whole Genome Sequencing 14%